Mabworks Biotech

2016-08-03​

Leading monoclonal antibody monoclonal antibody drug development and manufacturing enterprises

Early stage VC investment


Mabworks Biotech is high-tech company that develops and produces antibody-based drugs. The team is composed of professionals with work experience in Roche, Amgen and etc.


At present, the day has a wealth of real broad antibody drug product lines, military special declaration approved drug 2; industrialization has been declared autonomous anti-tumor monoclonal antibody 3, like Avastin in a clinical, MIL62 innovative varieties approved soon huge potential; innovative research projects in the reserve over 10 varieties, covering cancer, autoimmune, cardiovascular field.